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Abstract
Gene expression levels are regulated at many levels.
Integration of genome-wide analyses for the study of
DNA and RNA provides a unique tool to detect genetic
alterations in the cancer genome. In this study, we
generated and integrated DNA amplification data from
comparative genomic hybridization (CGH) and serial
analyses of gene expression (SAGE) in order to obtain a
molecular profile of gastroesophageal junction (GEJ)
carcinomas. DNA amplifications mapped to specific
chromosomal regions and were frequently seen at 1q,
4q, 5q, 6p, 7p, 8q, 17q, and 20q. Using SAGE, we
obtained over 156,432 tags fromGEJ adenocarcinomas
and normal gastric mucosa. These tags were assigned
to UniGene clusters. Chromosomal positions for over-
expressed genes were obtained to produce a GEJ
carcinoma transcriptomemap. A total of 123 genes was
significantly overexpressed (more than fivefold;P < .01)
in one or more SAGE libraries. This gene overexpres-
sion map was integrated and compared to the chromo-
somal CGH ideogram. Several chromosomal arms that
had frequent DNA amplifications showed frequent
gene expression alterations such as chromosomes 1
(15 genes), 2 (9 genes), 6 (6 genes), 11 (6 genes), 12
(8 genes), and 17 (13 genes). Despite the relatively large
DNA amplification regions, overexpressed genes fre-
quently mapped and clustered to small chromosomal
regions at early-replicating (Giemsa light) bands such
as 1q21.3 (nine genes), 6p21.3 (five genes), and 17q21
(eight genes). These results provide a comprehensive
tool to search for DNA amplifications and overex-
pressed genes in GEJ carcinoma. The observed
phenomenon of the presence of large amplification
areas, yet clustering of overexpressed genes to rela-
tively small loci, may suggest a high organization of
chromatin and cancer-related genes in the nucleus.
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Introduction
Gastroesophageal junction (GEJ) carcinomas have the
most rapidly rising incidence of all visceral malignancies in
the United States and Western world [1,2]. The majority of GEJ
carcinomas are sporadic and exhibit various levels of DNA
ploidy and chromosomal instability [3]. Comprehensive DNA
copy number analyses using comparative genomic hybridiza-
tion (CGH) have been widely used to characterize the DNA
alteration in several cancer types. CGH can demonstrate
recurrent DNA copy number changes and map them to chro-
mosomal locations [4]. The development of serial analyses of
gene expression (SAGE) technology has enabled genome-
wide unlimited comprehensive profile of gene expression in a
given cell population, representing the entire transcriptome
[5,6]. This method has been valuable in studies of several
tumor types including adenocarcinomas of the colon [7,8],
prostate [9], pancreas [10], ovary [11], and breast [12].
Analyses of the human transcriptome map have shown
clustering of highly expressed genes in chromosomal
domains [13]. Chromosomal arms and bands are known to
occupy specific locations within the nucleus known as chro-
mosome territories (CTs). The positioning of a gene(s) can
influence its access to the machinery responsible for specific
nuclear functions such as transcriptional level and splicing
[14]. In this study, we have globally explored the genome of
GEJ carcinomas at the DNA and RNA levels, and mapped
the DNA and gene expression changes to chromosomal
positions, thereby generating a comprehensive genetic map
of this deadly disease.
Materials and Methods
CGH
CGH was performed on 18 xenografted carcinomas that
were generated from fresh tissues from surgically resected
carcinomas of the lower esophagus (n = 3) or GEJ (n = 15).
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Xenografting was performed as previously described [15].
We and others have shown that xenografted tumor tissues
provide a pure source to study gene amplification and
expression similar to primary tumor samples [16,17]. Mice
were examined for tumor growth, and neoplasms were
harvested and frozen upon reaching approximately 1 cm in
diameter. High molecular weight genomic DNA was pre-
pared from these frozen xenografted tumors by standard
organic extraction methods. Histologic confirmation of the
xenografted tumors was performed on cryostat-sectioned
slides stained with hematoxylin and eosin (H&E). The CGH
experiments were performed using a mixture of fluoro-
chromes conjugated to dCTP and dUTP nucleotides for nick
translation. Hybridizations, washings, and ISIS digital image
analysis (Metasystems GmbH, Altlussheim, Germany) were
performed as described elsewhere [18]. All the CGH results
were confirmed using a 99% confidence interval. In each
CGH experiment, a negative control (peripheral blood DNA
from a healthy donor) and a positive control were included.
Based on our earlier reports and the control results, we used
1.17 for DNA amplifications and 1.50 for high-level amplifi-
cations (HLAs).
SAGE
High-quality total RNA (500 mg) was extracted using
RNeasy kit (QIAGEN GmbH, Hilden, Germany) from two
dissected GEJ adenocarcinomas and a pool of four normal
gastric epithelia biopsy samples that came from four patients
who were referred for endoscopy for dyspepsia or for
screening prior to gastric bypass surgery for obesity. The
two tumors that were used in SAGE had closely similar
pathological characters. GSM757 is a GEJ adenocarcinoma
(T4N0M0, moderately differentiated). GSM2385 is a GEJ
adenocarcinoma (T4N0M0, poorly differentiated). All normal
samples had histologically normal mucosa confirmed on
review of H&E–stained sections. Importantly, histopathology
examination confirmed that none of the normal samples had
any areas of inflammation or necrosis. The tumors selected
for SAGE analysis were estimated to consist of more than
80% tumor cells. All samples were collected after obtaining
informed consent in accordance with the Human Investiga-
tion Committee regulations at the University of Virginia.
SAGE libraries were constructed using NlaIII as the an-
choring enzyme and BsmFI as the tagging enzyme, as de-
scribed in SAGE protocol version 1.0e, June 23, 2000, which
includes a few modifications of standard protocol [5]. A
detailed protocol and schematic of the method is available
(http://www.sagenet.org/sage_protocol.htm). Two thousand
clones were sequenced for each case by the Cancer Ge-
nome Anatomy Project (CGAP). We used eSAGE 1.2a
software to extract SAGE tags, remove duplicate ditags,
tabulate tag contents, and link SAGE tags in the database
to UniGene clusters using the recently reported ehm-Tag-
Mapping method [19,20]. The resulting tag libraries tags
were compared to UniGene cluster and to the SAGE tag
‘‘reliable’’ mapping database (ftp://ftp.ncbi.nih.gov/pub/sage/
map/Hs/Nla3/), and statistical analyses were performed
using the eSAGE software. We have only included tags that
had reliable gene hits. Tags with multiple gene hits were
considered nonspecific and excluded from further analyses.
Significant changes in levels of expression (P V .01) were
determined.
Quantitative Real-Time Polymerase Chain Reaction (PCR)
For quantitative real-time PCR, 20 primary GEJ cancers
and 13 normal gastric epithelial samples were collected.
All tumors and normal gastric mucosal epithelial tissues
were verified by our histopathologist (H.F. and C.M.). The
collected tumors ranged from well-differentiated (WD) to
poorly differentiated (PD) stages I–IIIa, and there was a
mix of intestinal and diffuse-type tumors. The mRNA was
isolated using RNeasy kit (QIAGEN GmbH). Single-strand-
ed cDNA was synthesized using AdvantageTM RT-for-PCR
Kit (Clontech, Palo Alto, CA). Quantitative PCR was per-
formed using iCycler (Bio-Rad, Hercules, CA) and thresh-
old cycle number was determined using iCycler software
Table 1. DNA Copy Number Gains and Amplifications Using CGH on 18 GEJ and Esophageal Adenocarcinomas.
Case NumberGains and HLAs (in bold)
1 12p13, 17q, 20q12-q13.1
2 1p31.2-pter (1p34.2-pter), 1q , 3p14-pter, 3q13.2-q24, 5q31-qter, 7p, Xp, 8p, 8q22-qter, 10p, 11q (11q23.3-qter), 16p, 17q12-q21, 18, 19q, 20q
3 1p32-pter, 5p, 6p, 7p, 10p, 15q21-qter, 16p, 17q, 20q (20q12-13.1), 22
4 1q, 2pter-q14.3, 3p22-pter, 3q21-qter (3q24-q26.3), 4p, 5p, 6q22-qter, 7q21.2-q22.1, 8p (8p21-pter), 8q21.1-qter, 11q13, 12pter-q15, 12q23-qter,
14q13-qter, 15q22-qter, 17q, 20 (20q13), 22
5 1q, 2q31-q33, 7p, 8q (8q24), 10q, 12, 15q24-qter, 17q22, 19q, 20
6 1q, 3q21-qter, 5p, 6p11-p21, 7pter-q22, 8q21.2-qter, 10q24-qter, 17q, 18, 20q, 21
7 1q21-qter, 2p, 3 (3q25-q26.1, 3q27-q28), 5p12-p13.1, 6p, 7p, 8q, 11p14-qter, 12p12, 12q14-q15, 12q24-q25, 14q11-q21, 17q, 19q, 20 (20q)
8 1q21-qter, 2q, 3p24-pter, 7, 8q, 10pter-q22, 10q25-qter, 12p12, 12q14-q15, 12q24.2-qter, 14q11-q21, 17q, 18, 19q, 20q
9 1q21-qter, 2q31, 2q33-q34, 5p, 6pter-q24 (6p), 7p, 8q22-qter, 10, 11q13.4-q14, 12, 13, 15q21-qter, 16q12-qter, 17q12, 20, 22
10 1q32-qter, 3q13.3-q23, 3q27-qter, 7q32-qter, 9q, 17q, 20q
11 2q (2q32-q34), 3q, 6p, 7q11-q31, 10q, 12, 13q13-q21, 17, 18p, 20
12 3p21-pter, 7p14-q31 (7q21-q31), 8, 14q11-q24.1, 17q, 20, 22
13 3q13.3-q23, 6p21.2-p21.3, 7p, 8q24, 12p12-pter, 14q21-qter, 19q, 20q
14 4q11-q13, 6q22-q24, 7p21-pter, 8q23-qter, 11q11-q13, 17q, 19q, 20
15 4q11-q21, 7q21, 8p22-p23, 12q14-q15, 15q25-q26, 17q21.2-qter, 19q, 20q
16 6p21, 7p (7p13-pter), 8q21.3-qter (8q23-qter)
17 7pter-q21 (7p11-p13), 8q (8q24), 10pter-q22, 12q21-qter, 17q (17q11-q21.2), 19q, 20q, Xp
18 8q22-qter, 9q, 10q21-q22, 11q13-q14, 12p, 17q22-qter, 20
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version 3.0. Reactions were performed in triplicate and
threshold cycle numbers were averaged. Gene-specific
primers for 11 genes (LGALS3BP, PPP1R1B, HSPA5,
TACSTD1, ANXA1, TOP2A, S100A6, S100A7, S100A8,
S100A9, and S100A10 ) were designed. These genes were
chosen to cover different chromosomal locations and to be
representative of different levels of gene overexpression in
SAGE data. The primers used for RT-PCR were obtained
from GeneLink (Hawthorne, NY), and their sequences
are available on request. The results were normalized to
b-amyloid precursor protein (APP), which had minimal
variation in all normal and neoplastic GEJ samples that
we tested. Fold overexpression was calculated according
to the formula 2(RtEt)/2(RnEn), as earlier described [21],
Figure 1. Chromosomal ideogram showing DNA amplifications and gene overexpression alterations in GEJ carcinomas. Chromosomes are arranged vertically
next to each other. Chromosome numbers are shown on the left-hand side. DNA amplifications are shown at the right-hand side of the chromosome. The scale at
the bottom indicates the frequency (%) of the change. Gene expression alterations are also shown. Overexpression changes are shown at the right-hand side of
the chromosome. The length of the horizontal bar correlates with the number of altered genes in a given chromosomal location. The scale is shown at the bottom.
The highest gene clusters are seen at 1q21.3, 6p21.3, and 17q21.
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GGTTTGGCTT UQCRH 285761 1p33 2 30 34 5.90 <0.01 6.50 <0.01
CGCCGACGAT G1P3 287721 1p35 2 57 62 11.20 <0.001 11.90 <0.001
TTTCCTCTCA SFN 184510 1p35 0 27 27 10.60 <0.001 10.30 <0.001
TTTGCACCTT HMGN2 181163 1p36.1 0 9 17 3.50 0.073 6.50 <0.01
CTCTAAGAAG C1QA 9641 1p36.3 0 28 22 11.00 <0.001 8.40 <0.01
AATCTGCGCC G1P2 833 1p36.3 0 53 18 20.80 <0.001 6.90 <0.01
GGCTGGGGGC COAS3 352407 1q21.3 7 108 78 6.10 <0.001 4.30 <0.001
GATCTCTTGG S100A2 413843 1q21.3 0 2 46 1.30 0.741 17.60 <0.001
CAGGCCCCAC S100A11 417004 1q21.3 0 27 32 10.60 <0.001 12.20 <0.001
CCCCCTGGAT S100A6 275243 1q21.3 2 83 57 16.30 <0.001 10.90 <0.001
GAGCAGCGCC S100A7 112408 1q21.3 0 0 75 N/A N/A 28.70 <0.001
TACCTGCAGA S100A8 416073 1q21.3 0 0 284 N/A N/A 108.60 <0.001
GTGGCCACGG S100A9 112405 1q21.3 0 0 334 N/A N/A 127.70 <0.001
GGCTTCTAAC SPR-2A 505352 1q21.3 0 0 27 N/A N/A 10.30 <0.001
AGCAGATCAG S100A10 143873 1q21.3 1 48 95 18.80 <0.001 36.30 <0.001
GGCTGGTCTG MGC4677 446688 2p11.2 0 18 14 7.10 <0.01 5.40 0.016
GAAACCCCAG IGKC 306357 2p11.2 0 2 33 1.30 0.741 12.60 <0.001
GGGGAAATCG THYB10 446574 2p11.2 6 88 104 5.80 <0.001 6.60 <0.001
AGTTTGTTAG TACSTD1 692 2p21 0 29 56 11.40 <0.001 21.40 <0.001
TTGTTGTTGA CALM2 425808 2p21 0 19 6 7.50 <0.01 2.30 0.207
TCATCTTTAT RPS7 444012 2p25.3 0 16 0 6.30 <0.01 N/A N/A
TTCCTGGTAG U5-200 KD 246112 2q11.2 1 22 11 8.60 <0.01 4.20 0.177
TAAATAATTT HSPE1 1197 2q33.1 1 43 14 16.90 <0.001 5.40 0.080
ATCTTGTTAC FN1 418138 2q35 0 34 12 13.30 <0.001 4.60 0.030
TCACAGTGCC FLNB 81008 3p14.3 1 26 2 10.20 <0.01 1.30 1.385
GTGTTAACCA RPL15 74267 3p24.1 2 13 47 2.60 0.258 9.00 <0.001
CCCTCCCGAA MUC13 5940 3q21 0 5 16 2.00 0.274 6.10 <0.01
ATCCTTGCTG CSTA 412999 3q21 1 3 87 1.20 1.132 33.30 <0.001
GGGACGAGTG TM4SF1 351316 3q21 1 26 32 10.20 <0.01 12.20 <0.001
ACCTTTACTG TFRC 185726 3q29 0 17 5 6.70 <0.01 1.90 0.286
CCTGGTCCCA SH3BP2 167679 4p16.3 0 2 33 1.30 0.741 12.60 <0.001
CATATCATTA IGFBP7 435795 4q12 1 41 50 16.10 <0.001 19.10 <0.001
ACTAATCGTT RPL37 80545 5p13.1 0 18 6 7.10 <0.01 2.30 0.207
TTCACTGTGA TA-WDRP 175596 5q22.1 4 96 108 9.40 <0.001 10.30 <0.001
GTGACAACAC VDAC1 404814 5q31.1 2 18 31 3.50 0.080 5.90 <0.01
ATGTGAAGAG SPARC 111779 5q31.3 1 65 75 25.50 <0.001 28.70 <0.001
AATTTGCAAC H2AFY 75258 5q31.3 0 16 9 6.30 <0.01 3.40 0.078
CAGAGATGAA HSPA1A 75452 6p21.3 1 7 43 2.70 0.461 16.40 <0.001
ACCCTTTAAC HLA-E 381008 6p21.3 0 14 19 5.50 0.013 7.30 <0.01
AGCTTCTACC HLA-A 181244 6p21.3 0 0 24 N/A N/A 9.20 <0.001
GGGCATCTCT HLA-DRA 409805 6p21.3 3 61 87 8.00 <0.001 11.10 <0.001
GTACTGTGGC CLIC1 414565 6p21.3 0 2 18 1.30 0.741 6.90 <0.01
AAGGCAATTT TSPYL 278479 6q22.1 1 21 3 8.20 <0.01 1.10 1.153
CCCAAGCTAG HSPB1 76067 7q11.2 0 13 94 5.10 0.019 36.00 <0.001
TGCACAATAT MUC3B 129782 7q22 0 22 0 8.60 <0.001 N/A N/A
GTTCCACAGA COL1A2 232115 7q22 0 29 4 11.40 <0.001 1.50 0.396
CTGCCAAGTT ZYX 75873 7q34 0 11 19 4.30 0.038 7.30 <0.01
TGGGTGAGCC CTSB 135226 8p22 3 38 42 5.00 <0.01 5.40 <0.001
GAACGCCTAA DPYSL2 173381 8p22 0 25 8 9.80 <0.001 3.10 0.108
GCTAATAATG SULF1 409602 8q13.1 0 18 5 7.10 <0.01 1.90 0.286
ATTATTTTTC RPL7 421257 8q13.2 2 117 38 23.00 <0.001 7.30 <0.001
TAAGTGGAAT YWHAZ 386834 8q23.1 1 28 7 11.00 <0.01 2.70 0.482
CACTTCAAGG LY6E 77667 8q24.3 0 12 29 4.70 0.027 11.10 <0.001
AGAAAGATGT ANXA1 287558 9q21.1 0 56 138 22.00 <0.001 52.80 <0.001
AGCTGTATTC CKS2 83758 9q22.2 0 17 11 6.70 <0.01 4.20 0.041
TTTTCTGAAA TXN 395309 9q31 1 29 27 11.40 <0.001 10.30 0.002
TGCATCTGGT HSPA5 310769 9q33.3 3 60 29 7.80 <0.001 3.70 0.018
TCCAAATCGA VIM 435800 10p13 0 3 29 1.20 0.532 11.10 <0.001
AAAATACTAG DKK1 40499 10q21.1 0 17 0 6.70 <0.01 N/A N/A
TGATAATTCA MGC14697 171625 10q24.3 3 38 10 5.00 <0.01 1.30 0.860
TTTGGTTTTC RAB22A 21431 20q13.2 0 90 6 35.30 <0.001 2.30 0.207
ATATGTATAT CD44 306278 11p13 0 16 8 6.30 <0.01 3.10 0.108
TCTTGTGCAT LDHA 2795 11p15.1 1 51 19 20.00 <0.001 7.30 0.020
TAATAAATGC TTS-2.2 118463 11p15.5 0 31 7 12.20 <0.001 2.70 0.150
GGATTTGGCC RPLP2 437594 11p15.5 25 316 164 5.00 <0.01 2.50 <0.01
GCTGGTGCCT THY1 134643 11q23.3 0 2 16 1.30 0.741 6.10 <0.01
ACAGGCTACG TAGLN 433401 11q23.3 1 0 28 2.50 0.405 10.70 <0.01
GTCTCCTAAT RAI3 194691 12p13.1 0 18 10 7.10 <0.01 3.80 0.050
continued on next page
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where Rt is the threshold cycle number for the reference
gene observed in the tumor, Et is the threshold cycle
number for the experimental gene observed in the tumor,
Rn is the threshold cycle number for the reference gene
observed in the normal sample, and Rt is the threshold
cycle number for the reference gene observed in the tumor
sample. Rn and En values were an average for the 13
normals that were analyzed.
Results and Discussion
CGH analyses demonstrated complex DNA changes in all
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TGGTTTGAGC NDUFA9 75227 12p13.3 0 5 22 2.00 0.274 8.40 <0.001
AAGATTGGTG CD9 387579 12p13.3 0 10 53 3.90 0.050 20.30 <0.001
GAAGCACAAG KRT6A 334309 12q13.1 0 0 15 N/A N/A 5.70 0.011
GGCAGAGAAG KRT4 371139 12q13.1 0 0 29 N/A N/A 11.10 <0.001
CTGTTGATTG HNRPA1 356721 12q13.1 6 123 57 8.00 <0.001 3.60 <0.001
ATGTAAAAAA LYZ 234734 12q15 5 75 378 5.90 <0.001 28.90 <0.001
ACTCCAAAAA RNP24 75914 12q24.3 5 116 6 9.10 <0.001 2.20 1.831
TGAAAGTGTG HSP105B 36927 13q12.2 0 28 11 11.00 <0.001 4.20 0.041
TAATTTTTGC GW112 273321 13q14.3 0 0 211 N/A N/A 80.70 <0.001
CATCTGTACT PCDH20 391781 13q21.2 0 0 19 N/A N/A 7.30 <0.001
TTCACTGTGA LGALS3 411701 14q22 4 96 108 9.40 <0.001 10.30 <0.001
TACTAGTCCT HSPCA 446579 14q32.3 4 121 32 11.90 <0.001 12.20 <0.001
GAAATAAAGC IGHG3 413826 14q32.3 12 302 389 9.90 <0.001 12.40 <0.001
CAAACTAACC IGHM 153261 14q32.3 2 2 38 2.50 1.720 7.30 <0.001
CAGGAGGAGT GRP58 308709 15q15.3 0 1 16 2.50 1.032 6.10 <0.01
CTTCCAGCTA ANXA2 437110 15q22.2 2 27 29 5.30 <0.01 5.50 <0.01
TACTTGTGTG SDFR1 389371 15q24.1 1 23 5 9.00 <0.01 1.90 0.762
GCGACCGTCA ALDOA 273415 16p11.2 1 0 52 2.50 0.405 19.90 <0.001
CCCCCTGCAG MSLN 408488 16p13.3 0 105 5 41.20 <0.001 1.90 0.286
ACCGCCGTGG CYBA 68877 16q24 0 0 46 N/A N/A 17.60 <0.001
CCCAGAGCTC HSD17B2 155109 16q24 0 16 3 6.30 <0.01 1.10 0.548
AACTAATACT MGC40157 270232 17p11.2 6 108 14 7.10 <0.001 1.10 1.287
GAAACCCCAG HSA011916 84359 17p13 0 2 33 1.30 0.741 12.60 <0.001
ATAGACATAA C1QBP 78614 17p13 1 24 8 9.40 <0.01 3.10 0.378
GATCAATCAG CCL18 16530 17q21?? 0 16 3 6.30 <0.01 1.10 0.548
CTTCCTTGCC KRT17 2785 17q21.2 0 2 53 1.30 0.741 20.30 <0.001
AAAGCGGGGC KRT13 433871 17q21.2 0 0 73 N/A N/A 27.90 <0.001
CTGTTCCGGC PPP1R1B 286192 17q21.2 0 0 10 N/A N/A 4.00 0.050
CTCAGCAATG TOP2A 156346 17q21.2 0 4 5 1.60 0.700 2.00 0.050
GTGTGGGGGG JUP 2340 17q21.2 1 32 28 12.60 <0.001 10.70 <0.001
TTCGGTTGGT COL1A1 172928 17q21.3 1 66 41 25.90 <0.001 15.70 <0.001
TCTCCAGGAA CGI-69 237924 17q21.3 0 21 7 8.20 0.001 2.70 0.150
ATGCTCCCTG LGALS3BP 79339 17q25.3 0 0 18 N/A N/A 6.90 <0.01
TCTCTGATGC TIMP2 6441 17q25.3 1 40 23 15.70 <0.001 8.80 <0.01
CAACTTAGTT MLC-B 233936 18p11.3 2 19 29 3.70 0.062 5.50 <0.01
CCTCCTATTA RIOK3 209061 18q11.2 0 2 22 1.30 0.741 8.40 <0.01
ACCCCCCCGC JUND 2780 19p13.1 0 1 19 2.50 1.032 7.30 <0.01
AGAGGGTGGG DNAJB1 82646 19p13.1 1 30 36 11.80 <0.001 13.80 <0.001
CCTCCACCTA PRDX2 432121 19p13.2 2 28 15 5.50 <0.01 2.90 0.178
CGAGGGGCCA ACTN4 443619 19q13.2 1 1 39 2.50 1.613 14.90 <0.001
CGACCCCACG APOE 169401 19q13.2 0 22 51 8.60 <0.001 19.50 <0.001
TGGCCCCAGG APOC1 268571 19q13.2 0 34 56 13.30 <0.001 21.40 <0.001
GTACACACCC CST1 123114 20p11.21 0 1 19 2.50 1.032 7.30 <0.01
GTACACACAC CST4 56319 20p11.21 0 36 3 14.10 <0.001 1.10 0.548
TGTTCCACTC ENTPD6 438431 20p11.21 0 26 4 10.20 <0.001 1.50 0.396
AATGTGAGTC C20orf129 70704 20q11.23 0 20 17 7.80 <0.01 6.50 <0.01
TTGAATCCCC PI3 112341 20q13.1 0 0 62 N/A N/A 23.70 <0.001
GCCCCCAATA LGALS1 407909 22q13.1 2 38 26 7.50 <0.001 5.00 0.012
GAATTTTATA BZRP 202 22q13.2 1 22 9 8.60 <0.01 3.40 0.295
GAGAGTGTCT TIMP1 446641 Xp11.2 0 2 20 1.30 0.741 7.60 <0.01
ATTATCCAGG RBM3 301404 Xp11.2 0 18 0 7.10 <0.01 N/A N/A
CCCCCACCTA PLP2 77422 Xp11.2 0 23 5 9.00 <0.001 1.90 0.286
TATGTGTGCT SYTL4 376981 Xq22.1 0 18 0 7.10 <0.01 N/A N/A
GTTAACGTCC RPL36A 432485 Xq22.1 2 34 17 6.70 <0.01 3.30 0.112
ATAGAGGCAA MRGX 411358 Xq22.2 0 19 10 7.50 <0.01 3.80 0.050
Analyses were performed using eSAGE 1.2a software [19,20].
GSM784 = normal gastric mucosa; GSM2385 = gastroesophageal adenocarcinoma; GSM757 = gastroesophageal adenocarcinoma; Pval = P value.*
Table 2. Continued
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amplifications was detected, with 54 HLAs in different chro-
mosomal areas (Table 1). These amplifications were fre-
quently (>45%) seen in chromosome arms such as 1q, 6p,
7p, 8q, and 17q. Our results are in agreement with a similar
CGH study on GEJ carcinomas [22].
Global analyses of gene expression using SAGE libraries
producedmore than 156,432 expressed tags. Comparison to
UniGene cluster, release January 2003, identified 26,633
unique SAGE tags. Themost attractive feature of SAGE is its
ability to evaluate the expression pattern of thousands of
genes in a quantitative manner without prior sequence
information [23–26]. The genome-wide transcriptome anal-
yses for significant (P V .01) high expression changes
(z5-fold) revealed that 123 genes are overexpressed in
GEJ carcinomas as compared to normal mucosa (Table 2).
The overexpressed genes (P V .01) included several genes
that are cancer-related such as S100A proteins (A2, 6, 7, 8,
9, and 10), heat shock proteins (HSPE1, HSPA1A, HSPA5,
and HSPCA), protease inhibitors (SKALP, TIMP1, and
TIMP2), and proliferation markers (TOP2A, TGFA, RPS7,
and IGFBP7). In addition, there are several keratins that are
specific for epithelial cells such as keratin 4, 6A, 13, and 17
(Table 2). Sequence data from our SAGE libraries are
publicly available (http://www.ncbi.nlm.nih.gov/SAGE/) with
Geo Accession Omnibus nos. GSM757 and GSM2385 for
GEJ cancer and GSM784 for normal stomach. Our quanti-
tative real-time reverse transcription (RT) PCR for 11 over-
expressed genes confirmed the SAGE data (Figure 2).
However, we were not able to assess correlations with
histopathology data or clinical outcomes because of the
relatively small sample number in the pilot study.
We mapped gene expression alterations to chromosomal
positions using the University of California Santa Cruz’s
November freeze 2002 assembly of the human genome
sequence (http://genome.ucsc.edu) (Table 2). We Com-
pared the DNA amplification regions to the gene expression
mapping. The chromosome mapping of altered genes
revealed clustering of several genes to small chromosomal
domains, suggesting a high order of organization of the
cancer genome. Some chromosomal arms that had frequent
DNA changes had also frequent gene expression alterations
such as chromosomes 1 (15 genes), 2 (9 genes), 6 (6 genes),
11 (6 genes), 12 (8 genes), and 17 (13 genes) (Table 2;
Figure 1). Overexpressed genes clustered at specific chro-
mosomal positions such as 1q21.3 (9 genes), 6p21.3 (5
genes), and 17q21 (8 genes). The gene expression profile
indicated that although the amplification regions are often
large, the expressed genes are clustered and mapped to
small chromosomal regions such as 1q21.3 and 17q21.2.
This observation indicates that the majority of genes located
in areas involved in chromosomal amplifications remain
highly regulated and only few critical genes may be deregu-
lated and overexpressed. Although the DNA amplification is
one mechanism responsible for the expression changes,
other cellular mechanisms of gene regulation are often
involved (Table 2; Figure 1).
Despite the genome-wide chromosomal instability in GEJ
carcinomas, DNA gains and amplifications mapped to spe-
cific regions in the chromosomes such as 1q, 6q, and 17q.
When we reviewed the DNA changes that were reported in
73 tumor types from 283 reports [4], we observed that DNA
gains/amplifications map to chromosomal regions different
from losses in most human cancer types. Thus, the DNA
alterations are not randomly distributed but have a rather
unique distribution over the chromosomal domains.
Our analyses of the transcriptome in GEJ cancer dem-
onstrated clusters of overexpressed genes in a number of
early-replicating chromatin (Giemsa light bands) chromo-
somal domains such as 1q21.3, 6p21.3, and 17q21.2
(Figure 1). A recent comprehensive study of the human
transcriptome map demonstrated a similar clustering of
highly expressed genes in chromosomal domains [13].
There are growing evidences that chromosomes occupy
discrete CTs in the cell nucleus. The compartment for
gene-dense, early-replicating chromatin (Giemsa light
bands) is separated from the compartments for mid- to
late-replicating chromatin (Giemsa dark bands) [14,27]. A
novel theory for explaining gene expression has been re-
cently explored where the transcriptional status of genes
correlates with gene positioning in CTs where dynamic
repositioning of genes with respect to centromeric hetero-
chromatin has a role in gene silencing and activation [14,27].
Therefore, it is possible that the effect of DNA changes on
gene expression alterations may not be limited to their
respective gene copy numbers but also to the overall impact
of the massive DNA amplifications on the chromatin reposi-
tioning in the nucleus. The existence of other regulatory
mechanisms such as upstream gene regulation should not
be overlooked.
Our results provide a comprehensive tool to search for
DNA changes and genes that are overexpressed in GEJ
carcinoma. The presence of large amplification areas, yet
clustering of overexpressed genes to relatively small loci,
may suggest a high organization of chromatin and cancer-
related genes in the nucleus. The impact of massive DNA
Figure 2. Frequency histogram of gene overexpression in UGC (Upper
Gastrointestinal Carcinoma). Quantitative real-time RT-PCR analyses of 11
representative genes detected in SAGE analyses (LGALS3BP, PPP1R1B,
HSPA5, TACSTD1,ANXA1, TOP2A, S100A6, S100A7, S100A8, S100A9, and
S100A10). The gene expression in 20 primary GEJ cancers was compared to
13 normal gastric epithelial samples.Geneoverexpressionwas consideredat a
ratio z 5.0. The Overexpression fold was calculated as described earlier [21].
The vertical bars demonstrate the frequency of overexpression of the
corresponding gene in the GEJ cancer samples that we studied.
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changes that we detected in GEJ carcinomas on the nuclear
organization of the chromatin and the repositioning of genes
in CT requires further investigation. Moreover, the tran-
scriptome data provide us, as well as others, the opportunity
to develop functional and cell biology assays for particular
genes of interest that may serve as prognostic or therapeu-
tic targets. This is expected to add to the overall under-
standing of the biology of this genetically complex and
deadly cancer.
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